Kraig Biocraft Laboratories prepares for shipment of recombinant spider silk silkworm eggs to Vietnam
The Company expects to begin producing silk in fourth quarter
ANN ARBOR, Mich.--(BUSINESS WIRE)-- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that it is finalizing the details of its first shipment of the Company’s proprietary recombinant spider silk silkworm eggs to Vietnam. The Company is coordinating the details of this shipment with senior officials within key central Vietnamese government ministries, as well as senior leadership within Quang Nam province.
Kraig Labs will be working, in cooperation with leading sericulture experts in Vietnam, to demonstrate the performance and capabilities of the Company’s uniquely developed silkworms, as it moves to expand the production of its recombinant spider silk from pilot to full scale production.
“This shipment is a pivotal moment for Kraig Labs and a breakthrough in the commercialization of spider silk,” said the Company’s COO, Jon Rice. “The Company and our team of consultants in Vietnam, led by Mr. Ken Le, have worked tirelessly to make this shipment possible. Due to the unique nature of this project, we have had to work hand-in-hand with government officials in Vietnam to develop the required regulations and protocols. With all of the approvals in place, we are excited to be finalizing this first shipment, as we kick off the next phase of commercializing our spider silk technology.”
The Company expects to have all of the required documentation for this shipment completed within the next two to three weeks and expects to be raising its silkworms in Vietnam in the fourth quarter.
To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Hansel Capital, LLC
Ben Hansel, 720-288-8495
Source: Kraig Biocraft Laboratories, Inc.